Fig. 6From: Development and validation of a risk prediction score for patients with nasopharyngeal carcinomaThe prognostic model based on risk score, TNM stage and treatment predicting OS in the primary cohort (A) and the validation cohort (E). The calibration curves for predicting patient OS at 1-, 3-, 5-year in the primary cohort (B–D) and the validation cohort (F–H). Total points projected on the bottom scales indicate the probability of 1-, 3-, and 5-year survivalBack to article page